Temporal dynamics of genetically heterogeneous extended-spectrum cephalosporin-resistant

accessory genomes antimicrobial resistance clonal complex 131 copy-number variation extended-spectrum beta-lactamases extended-spectrum cephalosporin resistance molecular epidemiology

Journal

mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533

Informations de publication

Date de publication:
24 08 2023
Historique:
medline: 28 8 2023
pubmed: 10 7 2023
entrez: 10 7 2023
Statut: ppublish

Résumé

Extended-spectrum cephalosporin-resistant

Identifiants

pubmed: 37427953
doi: 10.1128/msphere.00183-23
pmc: PMC10449519
doi:

Substances chimiques

Cephalosporins 0
Anti-Bacterial Agents 0
Monobactams 0
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0018323

Commentaires et corrections

Type : UpdateOf

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Emerg Infect Dis. 2020 Dec;26(12):2907-2915
pubmed: 33219650
mBio. 2013 Dec 17;4(6):e00377-13
pubmed: 24345742
J Antimicrob Chemother. 2020 Jan 1;75(1):77-85
pubmed: 31613964
Clin Infect Dis. 2021 Dec 6;73(11):1992-1999
pubmed: 34143881
Mol Biol Evol. 1997 Jul;14(7):685-95
pubmed: 9254330
Microbiol Spectr. 2022 Jun 29;10(3):e0031922
pubmed: 35467393
Nat Microbiol. 2019 Mar;4(3):504-514
pubmed: 30742072
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S23-S33
pubmed: 30895212
PLoS One. 2019 Oct 29;14(10):e0224465
pubmed: 31661507
BMC Bioinformatics. 2018 Aug 29;19(1):307
pubmed: 30157759
Bioinformatics. 2018 Jul 1;34(13):i142-i150
pubmed: 29949969
mSystems. 2022 Oct 26;7(5):e0051922
pubmed: 35993734
N Engl J Med. 2020 Apr 2;382(14):1309-1319
pubmed: 32242356
Genome Med. 2021 Sep 3;13(1):144
pubmed: 34479643
J Antimicrob Chemother. 2021 Mar 12;76(4):901-908
pubmed: 33428729
Nucleic Acids Res. 2017 Jan 4;45(D1):D566-D573
pubmed: 27789705
Clin Microbiol Rev. 2019 Jun 12;32(3):
pubmed: 31189557
BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
Clin Infect Dis. 2021 Aug 16;73(4):565-574
pubmed: 33420788
BMC Infect Dis. 2021 Jun 25;21(1):606
pubmed: 34172003
Curr Opin Pharmacol. 2007 Oct;7(5):459-69
pubmed: 17875405
Front Cell Infect Microbiol. 2023 Jan 05;12:978643
pubmed: 36683701
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
Microb Genom. 2016 Apr 29;2(4):e000056
pubmed: 28348851
Curr Protoc Bioinformatics. 2020 Jun;70(1):e102
pubmed: 32559359
mSphere. 2021 Dec 22;6(6):e0086821
pubmed: 34935444
Genome Med. 2022 Dec 30;14(1):147
pubmed: 36585742
mSystems. 2022 Oct 26;7(5):e0047622
pubmed: 36036505
Antimicrob Agents Chemother. 2002 Jan;46(1):1-11
pubmed: 11751104
PLoS Comput Biol. 2022 Jul 25;18(7):e1010310
pubmed: 35877685
Antimicrob Agents Chemother. 2014 Sep;58(9):4997-5004
pubmed: 24867985
J Antimicrob Chemother. 2021 Jan 19;76(2):385-395
pubmed: 33164081
mBio. 2016 Mar 22;7(2):e02162
pubmed: 27006459
Epidemiol Infect. 2021 Aug 06;149:e195
pubmed: 34353396
Lancet Microbe. 2021 Jul;2(7):e331-e341
pubmed: 35544167
mBio. 2019 Apr 23;10(2):
pubmed: 31015329
mSphere. 2016 Jun 29;1(4):
pubmed: 27390780
mSystems. 2020 Sep 29;5(5):
pubmed: 32994286
Antimicrob Agents Chemother. 2012 May;56(5):2364-70
pubmed: 22354301
Epidemiol Infect. 2020 Feb 21;148:e68
pubmed: 32081112
Antimicrob Resist Infect Control. 2022 Nov 23;11(1):144
pubmed: 36424647
J Antimicrob Chemother. 2016 Sep;71(9):2484-8
pubmed: 27365186
Nat Commun. 2022 Dec 12;13(1):7490
pubmed: 36509735
Infect Control Hosp Epidemiol. 2016 Aug;37(8):946-953
pubmed: 27142942
Genome Med. 2021 May 5;13(1):77
pubmed: 33952335
BMC Bioinformatics. 2022 Oct 8;23(1):416
pubmed: 36209064
Clin Infect Dis. 2021 Mar 15;72(6):953-960
pubmed: 32149327
Clin Microbiol Infect. 2015 Oct;21(10):924-9
pubmed: 26141255
J Biol Chem. 2002 Jul 5;277(27):24155-61
pubmed: 11973328
Water Res. 2023 Mar 1;231:119648
pubmed: 36702023
J Antimicrob Chemother. 2019 Nov 1;74(11):3179-3183
pubmed: 31411684
Antimicrob Agents Chemother. 2010 Mar;54(3):969-76
pubmed: 19995920
Genome Res. 2017 Jul 18;:
pubmed: 28720578
Open Forum Infect Dis. 2019 Aug 11;6(8):ofz353
pubmed: 31401649
Clin Infect Dis. 2017 Sep 1;65(5):738-745
pubmed: 28472260
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Front Microbiol. 2021 Oct 11;12:730012
pubmed: 34707587
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349
Open Forum Infect Dis. 2017 May 02;4(2):ofx089
pubmed: 28638846
Emerg Infect Dis. 2016 Nov;22(11):1900-1907
pubmed: 27767006

Auteurs

William C Shropshire (WC)

Department of Infectious Diseases and Infection Control, The University of Texas MD Anderson Cancer Center , Houston, Texas, USA.

Benjamin Strope (B)

Program in Diagnostic Genetics and Genomics, MD Anderson Cancer Center School of Health Professions , Houston, Texas, USA.

Selvalakshmi Selvaraj Anand (S)

Program in Diagnostic Genetics and Genomics, MD Anderson Cancer Center School of Health Professions , Houston, Texas, USA.

Jordan Bremer (J)

Department of Infectious Diseases and Infection Control, The University of Texas MD Anderson Cancer Center , Houston, Texas, USA.

Patrick McDaneld (P)

Division of Pharmacy, The University of Texas MD Anderson Cancer Center , Houston, Texas, USA.

Micah M Bhatti (MM)

Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center , Houston, Texas, USA.

Anthony R Flores (AR)

Division of Infectious Diseases, Department of Pediatrics, McGovern Medical School, University of Texas Health Science Center , Houston, Texas, USA.

Awdhesh Kalia (A)

Program in Diagnostic Genetics and Genomics, MD Anderson Cancer Center School of Health Professions , Houston, Texas, USA.

Samuel A Shelburne (SA)

Department of Infectious Diseases and Infection Control, The University of Texas MD Anderson Cancer Center , Houston, Texas, USA.
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center , Houston, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH